These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8157562)

  • 1. Zinc ions and medium-dependent susceptibility to beta-lactams in Xanthomonas maltophilia.
    Bonfiglio G; Livermore DM
    J Antimicrob Chemother; 1994 Jan; 33(1):181-3. PubMed ID: 8157562
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of media composition on the susceptibility of Xanthomonas maltophilia to beta-lactam antibiotics.
    Bonfiglio G; Livermore DM
    J Antimicrob Chemother; 1991 Dec; 28(6):837-42. PubMed ID: 1816181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of divalent cations in bacteriological media on the susceptibility of Xanthomonas maltophilia to imipenem, with special reference to zinc ions.
    Hawkey PM; Birkenhead D; Kerr KG; Newton KE; Hyde WA
    J Antimicrob Chemother; 1993 Jan; 31(1):47-55. PubMed ID: 8444674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to beta-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 beta-lactamases.
    Akova M; Bonfiglio G; Livermore DM
    J Med Microbiol; 1991 Oct; 35(4):208-13. PubMed ID: 1941990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of 100 strains of Stenotrophomonas maltophilia to three beta-lactams and five beta-lactam-beta-lactamase inhibitor combinations.
    Lecso-Bornet M; Bergogne-Bérézin E
    J Antimicrob Chemother; 1997 Nov; 40(5):717-20. PubMed ID: 9421322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferable resistance to beta-lactams in a nosocomial strain of Xanthomonas maltophilia.
    Hupková M; Blahová J; Králiková J; Krcmery V
    Antimicrob Agents Chemother; 1995 Apr; 39(4):1011-2. PubMed ID: 7785971
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibilities of 97 strains of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
    Ismaeel NA
    Microbios; 1997; 91(367):97-103. PubMed ID: 9467924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cyclic nucleotides on beta-lactamase production and outer membrane proteins of clinical Xanthomonas maltophilia isolates].
    Cullmann W
    Immun Infekt; 1991 Feb; 19(1):3-7. PubMed ID: 1648031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
    Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T
    Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro susceptibility of Xanthomonas maltophilia to aztreonam and clavulanic acid as a test for the presumptive identification of the species.
    Townsend R; Winstanley TG; Spencer RC
    J Hosp Infect; 1991 Aug; 18(4):324-5. PubMed ID: 1682373
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical isolate of a Xanthomonas maltophilia strain producing L-1-deficient and L-2-inducible beta-lactamases.
    Bonfiglio G; Stefani S; Nicoletti G
    Chemotherapy; 1995; 41(2):121-4. PubMed ID: 7758355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
    Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
    APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of antimicrobial activity of aztreonam/clavulanic acid (2:1) against Xanthomonas maltophilia.
    García-Rodríguez JA; García Sánchez JE; Muñoz Bellido JL; García García MI; García Sánchez E
    J Antimicrob Chemother; 1991 Apr; 27(4):552-4. PubMed ID: 1856134
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic susceptibility of Stenotrophomonas (Xanthomonas) maltophilia: comparative (NCCLS criteria) evaluation of antimicrobial drugs with the agar dilution and the agar disk diffusion (Bauer-Kirby) tests.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(3):164-73. PubMed ID: 9612606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aztreonam-clavulanic acid synergy does not mean extended-spectrum beta-lactamase in Stenotrophomonas maltophilia.
    Muñoz Bellido JL; García-Rodriguez JA
    J Antimicrob Chemother; 1998 Apr; 41(4):493-4. PubMed ID: 9598782
    [No Abstract]   [Full Text] [Related]  

  • 16. Temperature-dependent aminoglycoside resistance in Stenotrophomonas (Xanthomonas) maltophilia; alterations in protein and lipopolysaccharide with growth temperature.
    Rahmati-Bahram A; Magee JT; Jackson SK
    J Antimicrob Chemother; 1996 Apr; 37(4):665-76. PubMed ID: 8722532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stenotrophomonas maltophilia in cystic fibrosis patients.
    Ballestero S; Vírseda I; Escobar H; Suárez L; Baquero F
    Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):728-9. PubMed ID: 8565998
    [No Abstract]   [Full Text] [Related]  

  • 18. Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(5):293-304. PubMed ID: 9732143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
    Dornbusch K; Adamsson L; Gezelius L; Hallander H
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():113-21. PubMed ID: 6460739
    [No Abstract]   [Full Text] [Related]  

  • 20. Outer membrane protein profiles of Xanthomonas maltophilia isolates displaying temperature-dependent susceptibility to gentamicin.
    Wilcox MH; Winstanley TG; Spencer RC
    J Antimicrob Chemother; 1994 Mar; 33(3):663-6. PubMed ID: 8040133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.